We detected an enrichment of hTERT mutations in NAFLD‐HCC, that was confirmed when we further considered a larger cohort of NAFLD‐PLC, and was more marked in female patients (P = 0.03). Here, HSPG2 is linked to metabolic dysfunction-associated steatotic liver disease.